Clinical Trial Update: Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating MRI with gadoxetic acid for non-invasive diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• EOVIST (GADOXETATE DISODIUM)
• Primovist (Gadoxetate disodium)

Snippet

Sponsor: Sara Varea | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: COMPLETED